KOSDAQ · Healthcare · ₩263B
₩23,100+1.76%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 4.2% · as of 26.10.27
Among 98 제약 peers
Quarterly Revenue Growth
“제품과 상품이 함께 살아나며 실적 회복을 이어가고 있어요.”
In the company's words · 2026 2분기 filing